Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,328,918
+$272,437 QoQ
Shares Held
17,045
+2.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#1,719
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETARY MANAGEMENT GROUP INC holds $39,611,391 across 9 Drug Manufacturers - General names. JNJ ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,775 | $17,721,579 | |
| 2 | ABBV |
AbbVie Inc.
|
35,105 | $8,833,822 | |
| 3 | AMGN |
Amgen Inc
|
13,171 | $4,769,482 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
17,045 | $4,328,918 | |
| 5 | MRK |
Merck & Co., Inc.
|
15,685 | $2,015,522 | |
| 6 | PFE |
Pfizer Inc
|
38,004 | $915,136 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,850 | $798,037 | |
| 8 | NVS |
Novartis AG
|
1,259 | $197,310 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,328,918 | 17,045 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,056,481 | 16,595 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,434,335 | 16,595 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,262,464 | 17,595 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,744,917 | 17,970 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,880,640 | 17,370 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,584,359 | 17,870 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,803,638 | 17,300 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,437,218 | 16,675 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $2,872,255 | 18,157 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,641,069 | 16,850 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,733,412 | 17,550 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,904,876 | 17,550 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,720,250 | 17,550 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,139,953 | 17,775 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,944,564 | 18,025 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,199,617 | 18,025 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,194,570 | 18,025 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,963,787 | 17,325 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,636,487 | 16,325 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,512,285 | 15,250 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,210,577 | 19,535 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,058,680 | 19,435 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,889,760 | 19,410 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,729,628 | 19,410 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,797,658 | 21,335 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||